全球肾上腺素注射器市场：按类型、最终用户、分销管道、地区

全球肾上腺素注射器市场预计将从 2023 年的 22 亿美元增至 2030 年的 39.1 亿美元，预测期内复合年增长率为 8.6%。

图 1. 2023 年肾上腺素注射器的全球市场占有率(%)（按地区）

肾上腺素注射器是一次性自动注射器，用于紧急治疗过敏反应，包括过敏反应。过敏反应是一种危及生命的疾病，由对某些食物、药物、昆虫叮咬或其他过敏原的极度过敏反应引起。过敏反应的症状包括低血压、口腔和喉咙肿胀、皮疹、呼吸困难和休克。如果发生过敏反应，必须及时给予肾上腺素以减缓症状的进展。与注射器相比，肾上腺素注射器可以快速自我注射肾上腺素，从而降低伤亡风险。

市场动态：

全球肾上腺素注射器市场的成长是由全球过敏反应盛行率上升所推动的。根据FAAN（食物过敏和过敏反应网路）公布的资料，光是美国每年就有5万例过敏反应病例，其中150至200例导致死亡。人们对与过敏相关的危及生命的疾病的认识不断提高，以及先进肾上腺素注射器的可用性正在刺激市场需求。然而，这些设备的成本以及新兴国家对替代治疗方案的偏好限制了市场的成长。创新肾上腺素注射器的开发具有更高的易用性、准确性和更广泛的应用范围，预计将在未来几年为製造商带来利润丰厚的机会。

由于技术进步、对过敏反应的认识不断提高以及对使用者友善设计的日益重视，肾上腺素注射器市场正在见证显着的趋势。无针替代品和培训的数位健康平台备受关注，提高了患者的舒适度和可及性。市场也在应对疫情后不断变化的情况，要求医疗保健系统和供应链具有适应性。持续的技术创新、改进的设备功能和策略联盟正在进一步塑造肾上腺素注射器市场的动态，以满足快速变化的医疗环境中高风险个人和医疗保健提供者的需求。我们的目标

本研究的主要特点

本报告对全球肾上腺素注射器市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球肾上腺素注射器市场的主要企业进行了介绍。

主要公司包括 Mylan、Teva Pharmaceutical、Impax Laboratories、Adamis Pharmaceuticals Corporation、Pfizer、ALK Abello、Lincoln Medical、Hospira、Sanofi 和 Kaleo。

从这份报告中获得的见解将帮助行销人员和公司负责人就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球肾上腺素注射器市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过分析全球肾上腺素注射器市场时所使用的各种策略矩阵，促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 服务交付组合
• PEST分析
• 波特的分析
• 併购场景
• 管道分析

第四章全球肾上腺素注射器市场－冠状病毒 (COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球肾上腺素注射器市场，依类型，2018-2030

• 15mg
• 3mg
• 5mg

第 6 章 全球肾上腺素注射器市场，按最终用户划分，2018-2030 年

• 医院
• 诊所
• 个人客户

第7章2018-2030年全球肾上腺素注射器市场（依通路）

• 零售药房
• 医院药房
• 网路药房

第8章2018-2030年全球肾上腺素注射器市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章 竞争形势

• Mylan
  • Type Portfolio
• Teva Pharmaceutical
• Impax Laboratories
• Adamis Pharmaceuticals Corporation
• Pfizer
• ALK Abello
• Lincoln Medical
• Hospira
• Sanofi
• Kaleo

第10章

• 调查方法
• 关于出版商

Global epinephrine autoinjector market is expected to reach US$ 3.91 Bn by 2030, from US$ 2.20 Bn in 2023, exhibiting a CAGR of 8.6% during the forecast period.

Figure 1. Global Epinephrine Autoinjector Market Share (%), By Region, 2023

Epinephrine autoinjector is a single-use disposable automatic injection device that is intended for emergency treatment of allergic reactions including anaphylaxis. Anaphylaxis is a life-threatening condition that occur due to an extreme allergic reaction to certain foods, medicines, insects bites and other allergens. The symptoms of anaphylaxis include low blood pressure, swelling of the mouth or throat, rashes, breathing difficulty and shock. In case of anaphylaxis, epinephrine needs to be administered in a timely manner to curb the advancement of symptoms. Epinephrine autoinjectors enable rapid self-administration of epinephrine as compared to syringes, thereby, reducing the risk of casualty.

Market Dynamics:

Global epinephrine autoinjector market growth is driven by rising prevalence of anaphylaxis worldwide. According to the data published by FAAN (The Food Allergy and Anaphylaxis Network), 50,000 cases of anaphylaxis occur annually in the U.S. alone, out of which 150-200 result in death. Increased awareness regarding life-threatening conditions associated with allergies along with availability of advanced epinephrine autoinjector devices are fueling the market demand. However, cost of these devices and preference for alternative treatment options in developing nations limits the market growth. Development of innovative epinephrine autoinjectors with improved usability, accuracy and larger coverage area is expected to present lucrative opportunities for manufacturers in the coming years.

The epinephrine autoinjector market is witnessing notable trends, driven by advancements in technology, increased awareness of anaphylaxis, and a growing emphasis on user-friendly designs. Needle-free alternatives and digital health platforms for training are gaining prominence, enhancing patient comfort and accessibility. The market is also responding to the evolving landscape influenced by the pandemic, necessitating adaptability in healthcare systems and supply chains. Continuous innovation, improved device features, and strategic collaborations are further shaping the dynamics of the epinephrine autoinjector market, aiming to address the needs of at-risk individuals and healthcare providers in a rapidly changing healthcare environment.

Key features of the study:

This report provides in-depth analysis of the global epinephrine autoinjector market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global epinephrine autoinjector market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Mylan, Teva Pharmaceutical, Impax Laboratories, Adamis Pharmaceuticals Corporation, Pfizer, ALK Abello, Lincoln Medical, Hospira, Sanofi, and Kaleo

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global epinephrine autoinjector market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epinephrine autoinjector market

Detailed Segmentation:

• Global Epinephrine Autoinjector Market, By Type
  • 15mg
  • 3mg
  • 5mg
• Global Epinephrine Autoinjector Market, By End-User
  • Hospitals
  • Clinics
  • Individual Customers
• Global Epinephrine Autoinjector Market, By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
• Global Epinephrine Autoinjector Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Global Epinephrine Autoinjector Market, Key Players
  • Mylan
  • Teva Pharmaceutical
  • Impax Laboratories
  • Adamis Pharmaceuticals Corporation
  • Pfizer
  • ALK Abello
  • Lincoln Medical
  • Hospira
  • Sanofi
  • kaleo

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Epinephrine Autoinjector Market, By Type
  • Global Epinephrine Autoinjector Market, By End User
  • Global Epinephrine Autoinjector Market, By Distribution Channel
  • Global Epinephrine Autoinjector Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing prevalence of anaphylaxis
  • Rising Prevalence of Food Allergies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Epinephrine Autoinjector Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Epinephrine Autoinjector Market, By Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• 0.15mg
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• 0.3mg
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• 0.5mg
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Epinephrine Autoinjector Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Individual Customers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Epinephrine Autoinjector Market, By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Epinephrine Autoinjector Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Mylan
  • Company Highlights
  • Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teva Pharmaceutical
• Impax Laboratories
• Adamis Pharmaceuticals Corporation
• Pfizer
• ALK Abello
• Lincoln Medical
• Hospira
• Sanofi
• Kaleo
• Analyst Views

10. Section

• Research Methodology
• About us